You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 11, November 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Macular Disorders
 •Retinal/ Chorioretinal Disorders
 •Vitreous Disorders
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Effects of Intravitreous Injection of Preserved and Nonpreserved Triamcinolone in Rabbit Retina

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article by Dierks et al1 comparing the short-term effects of intravitreal injection of Kenalog-40 (Bristol-Myers Squibb, Princeton, NJ) with intravitreal injection of the vehicle and of triamcinolone acetonide in rabbit eyes. A 10% to 25% increase in a- and b-wave electroretinographic amplitudes of eyes with intravitreal injection of Kenalog-40 or triamcinolone compared with noninjected eyes was reported, although the probability of this being a chance finding (P value) was not stated.

Furthermore, the ratio of a- and b-wave amplitudes in the injected eyes to control eyes was compared across groups; there were no statistical differences except for an increase in the dark-adapted b-wave amplitude ratio only between the Kenalog-40 and vehicle groups at only 1 of 7 stimulating intensities (there was no statistical difference comparing intravitreal injection of the vehicle with intravitreal injection of triamcinolone). Details concerning the Bonferroni correction, which adjusts for multiple . . . [Full Text of this Article]


AUTHOR INFORMATION
Petros E. Carvounis, BMBCh; Muhammad Abd El Barr, MS; Thomas A. Albini, MD; Eric R. Holz, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTER

Effects of Intravitreous Injection of Preserved and Nonpreserved Triamcinolone in Rabbit Retina—Reply
Dustin Dierks, Bo Lei, Keqing Zhang, and Dean P. Hainsworth
Arch Ophthalmol. 2006;124(11):1666-1668.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Electroretinographic Effects of an Intravitreal Injection of Triamcinolone in Rabbit Retina
Dustin Dierks, Bo Lei, Keqing Zhang, and Dean P. Hainsworth
Arch Ophthalmol. 2005;123(11):1563-1569.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.